Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382.

van Nieuwenhuijzen, P S

Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382. [electronic resource] - Neuroscience Sep 2014 - 700-15 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1873-7544

10.1016/j.neuroscience.2014.07.056 doi


4-Butyrolactone--pharmacology
Animals
Benzocycloheptenes--pharmacology
Brain--drug effects
Cell Count
Central Nervous System Agents--pharmacology
GABA-B Receptor Antagonists--pharmacology
Hypnotics and Sedatives--pharmacology
Immunohistochemistry
Male
Morpholines--pharmacology
Motor Activity--drug effects
Neurons--drug effects
Proto-Oncogene Proteins c-fos--metabolism
Random Allocation
Rats, Wistar
Sodium Oxybate--antagonists & inhibitors